Device trials regulation closer in Germany, but it’s a top-three concern for industry
This article was originally published in Clinica
Executive Summary
A forum on innovative medtech in Germany, hosted by the TK (Techniker Krankenkasse) sickness fund at last week’s Medica (Düsseldorf), delved into the major preoccupations of stakeholders in national healthcare delivery.